PALO ALTO, Calif.--()--Affymax, Inc. (NASDAQ: AFFY) today announced the company's participation in the following investor conferences next week.
Rodman & Renshaw Annual Global Investment Conference
Tuesday, September 11, 2012
1:35 p.m. Eastern Time (10:35 a.m. Pacific Time)
Morgan Stanley Global Healthcare Conference
Wednesday, September 12, 2012
9:10 a.m. Eastern Time (6:10 a.m. Pacific Time)
A live webcast of the presentations will be available on the investors section of the Company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentations.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.
The company's first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.